Melanoma - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Treatment for Metastatic Ocular Melanoma
(Posted: 03/07/2006) - In this trial, researchers are testing a new drug called lenalidomide (Revlimid®) to see if it can stop or slow the growth of ocular melanoma metastases and help patients live longer.
- Targeted Combination Therapy for Advanced Solid Tumors
(Posted: 07/19/2005) - In this study, researchers are assessing the safety and combined effectiveness of bevacizumab and a second drug called sorafenib. Both bevacizumab and sorafenib inhibit the formation of blood vessels to tumors and may act synergistically when combined.
- Cell-Based Immunotherapy for Metastatic Melanoma
(Posted: 01/04/2005) - In this phase II trial, researchers are investigating a cell-based form of immunotherapy for stage IV melanoma that produced tumor shrinkage or disappearance in more than 50 percent of patients enrolled in an earlier part of the study.
- Study of Individuals and Families at High Risk for Melanoma
(Posted: 09/14/2004) - Researchers with this study are seeking members of families in which there are multiple cases of melanoma to identify genes and precursor conditions that may increase the likelihood of developing this disease.